Archive for the School of Biomedical Sciences Category

Turning to the gut to better understand depression

Can the community of microbes in our digestive track influence our mental state and, if so, how? That’s a focus of study by Monica Uddin, PhD, a professor […]

Studying interplay between gut microbiome and cancer treatments to reduce cardiac complications

The treatment of cancer may soon get a shot in the arm as researchers come closer to understanding the link between the disease and the diversity of microbes, […]

Exploring the link between the microbiome and colorectal disease

The future of medicine depends in part on a better understanding of the microbiome – communities of bacteria, fungi and other microbes in our bodies – and their […]

Sarah Yuan wins prestigious national award for microvascular research

Sarah Yuan, MD, PhD, professor and chair of the USF Health Morsani College of Medicine’s Department of Molecular Pharmacology and Physiology, has received the 2020 Eugene M. Landis […]

Brendan Walker studies brain changes driving addictive behaviors

The USF Health neuroscientist aims to translate his research on kappa opioid receptors into personalized treatments for alcoholism and other addictive disorders When USF Health neuroscientist Brendan Walker, […]

Tiny cargo carriers rich in c-Src protein contribute to disease progression

New USF Health research on endothelial-derived microvesicles, using models of sepsis, may be useful for better diagnosis and treatment of inflammatory or infectious diseases A new preclinical study […]

Clinic integrates care and genetic research for patients with neuromuscular disorders

USF Health has established a Neurocardiogenetics Clinic focused on improving the quality of life for patients with hereditary neuromuscular disorders who are at risk for or already experiencing […]

Leading expert on role of immune cells in atherosclerosis featured at Heart Institute scientific colloquium

A leading expert on the role of monocytes and macrophages (types of immune cells) in atherosclerosis and other chronic inflammatory conditions delivered the keynote address Nov. 7 at […]

Symposium updates Friedreich’s ataxia community on advances against FA

The USF Health Ataxia Research Center was one of 11 sites in the Phase 2 clinical trial of omaveloxolone, which may prove key to the drug becoming the […]

Silencing RNA nanotherapy shows promise against pancreatic cancer

A Washington University-USF Health preclinical study finds that the novel nanoparticle delivers gene-level treatment to suppress KRAS-driven cancer without adverse effects Despite advances in cancer survival, more than […]